Fecal Carriage of Extended-Spectrum β-Lactamase and Carbapenemase-Producing Enterobacterales Strains in Patients with Colorectal Cancer in the Oncology Unit of Amizour Hospital, Algeria: A Prospective Cohort Study,Microbial Drug Resistance

当前位置： X-MOL 学术 › Microb. Drug Resist. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Fecal Carriage of Extended-Spectrum β-Lactamase and Carbapenemase-Producing Enterobacterales Strains in Patients with Colorectal Cancer in the Oncology Unit of Amizour Hospital, Algeria: A Prospective Cohort Study
Microbial Drug Resistance ( IF 2.6 ) Pub Date : 2020-10-28 , DOI: 10.1089/mdr.2019.0350
Abdelaziz Touati ₁ , Melissa Talbi ₁ , Assia Mairi ₁ , Abdelaziz Messis _{2,

3} , Ahmed Adjebli ₁ , Mustapha Louardiane ₄ , Jean Philippe Lavigne _{5,

6}

Affiliation

Background: The prevalence of extended-spectrum β-lactamase (ESBL)-producing Enterobacterales (ESBL-E) and carbapenemase-producing Enterobacterales (CPE) is now disseminated worldwide. This study aims to describe the prevalence of ESBL and CPE fecal carriage in colorectal cancer patients.

中文翻译：

阿尔及利亚 Amizour 医院肿瘤科结直肠癌患者中超广谱 β-内酰胺酶和产碳青霉烯酶肠杆菌菌株的粪便携带：一项前瞻性队列研究

背景：产超广谱 β-内酰胺酶 (ESBL) 的肠杆菌 (ESBL-E) 和产碳青霉烯酶的肠杆菌 (CPE) 现在在世界范围内流行。本研究旨在描述结直肠癌患者中 ESBL 和 CPE 粪便携带的流行情况。

更新日期：2020-11-03

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>